Etiology including epigenetic defects of retinoblastoma
Asia-Pacific Journal of Ophthalmology · 2024
DOI: 10.1016/j.apjo.2024.100072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2024. Verfasst von Linbin Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hong Kong Food and Health Bureau, Health and Medical Research Fund, The Chinese University of Hong Kong.
Abstract (Originalsprache)
Retinoblastoma (RB), originating from the developing retina, is an aggressive intraocular malignant neoplasm in childhood. Biallelic loss of RB1 is conventionally considered a prerequisite for initiating RB development in most RB cases. Additional genetic mutations arising from genome instability following RB1 mutations are proposed to be required to promote RB development. Recent advancements in high throughput sequencing technologies allow a deeper and more comprehensive understanding of the etiology of RB that additional genetic alterations following RB1 biallelic loss are rare, yet epigenetic changes driven by RB1 loss emerge as a critical contributor promoting RB tumorigenesis. Multiple epigenetic regulators have been found to be dysregulated and to contribute to RB development, including noncoding RNAs, DNA methylations, RNA modifications, chromatin conformations, and histone modifications. A full understanding of the roles of genetic and epigenetic alterations in RB formation is crucial in facilitating the translation of these findings into effective treatment strategies for RB. In this review, we summarize current knowledge concerning genetic defects and epigenetic dysregulations in RB, aiming to help understand their links and roles in RB tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China.
- Medicine Programme Global Physician-Leadership Stream, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China.
- Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China; Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kon…
Förderung
- Hong Kong Food and Health Bureau
- Health and Medical Research Fund
- The Chinese University of Hong Kong
Zitieren
APA
Zhou, L., Tong, Y., Ho, B. M., Li, J., Chan, H. Y. E., Zhang, T., Du, L., He, J. N., Chen, L. J., Tham, C. C., Yam, J. C., Pang, C. P., & Chu, W. K. (2024). Etiology including epigenetic defects of retinoblastoma. Asia-Pacific Journal of Ophthalmology. https://doi.org/10.1016/j.apjo.2024.100072
Vancouver
Zhou L, Tong Y, Ho BM, Li J, Chan HYE, Zhang T, et al. Etiology including epigenetic defects of retinoblastoma. Asia-Pacific Journal of Ophthalmology. 2024. doi:10.1016/j.apjo.2024.100072
BibTeX
@article{Zhou2024,
author = {Zhou, Linbin and Tong, Yan and Ho, Bo Man and Li, Jiahui and Chan, Hoi Ying Emily and Zhang, Tian and Du, Lin and He, Jing Na and Chen, Li Jia and Tham, Clement C and Yam, Jason C and Pang, Chi Pui and Chu, Wai Kit},
title = {Etiology including epigenetic defects of retinoblastoma},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2024},
doi = {10.1016/j.apjo.2024.100072}
}
EUVIMED